- Home
- ZLAB vs SCL Comparison
ZLAB vs SCL Comparison
Compare ZLAB & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- SCL
- Stock Information
- Founded
- ZLAB 2013
- SCL 1932
- Country
- ZLAB China
- SCL United States
- Employees
- ZLAB N/A
- SCL N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- SCL Package Goods/Cosmetics
- Sector
- ZLAB Health Care
- SCL Consumer Discretionary
- Exchange
- ZLAB Nasdaq
- SCL Nasdaq
- Market Cap
- ZLAB 3.6B
- SCL 1.2B
- IPO Year
- ZLAB 2017
- SCL N/A
- Fundamental
- Price
- ZLAB $35.48
- SCL $57.54
- Analyst Decision
- ZLAB Buy
- SCL
- Analyst Count
- ZLAB 5
- SCL 0
- Target Price
- ZLAB $54.28
- SCL N/A
- AVG Volume (30 Days)
- ZLAB 852.9K
- SCL 89.4K
- Earning Date
- ZLAB 08-05-2025
- SCL 07-30-2025
- Dividend Yield
- ZLAB N/A
- SCL 2.67%
- EPS Growth
- ZLAB N/A
- SCL 47.62
- EPS
- ZLAB N/A
- SCL 2.45
- Revenue
- ZLAB $418,326,000.00
- SCL $2,222,111,000.00
- Revenue This Year
- ZLAB $44.07
- SCL $8.56
- Revenue Next Year
- ZLAB $49.13
- SCL $6.89
- P/E Ratio
- ZLAB N/A
- SCL $23.50
- Revenue Growth
- ZLAB 43.72
- SCL N/A
- 52 Week Low
- ZLAB $16.01
- SCL $44.23
- 52 Week High
- ZLAB $44.34
- SCL $94.77
- Technical
- Relative Strength Index (RSI)
- ZLAB 49.40
- SCL 57.85
- Support Level
- ZLAB $34.79
- SCL $54.28
- Resistance Level
- ZLAB $36.97
- SCL $59.57
- Average True Range (ATR)
- ZLAB 1.20
- SCL 1.50
- MACD
- ZLAB -0.43
- SCL 0.35
- Stochastic Oscillator
- ZLAB 15.39
- SCL 66.61
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About SCL Stepan Company
Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.